Metagenics Inc. Announces Groundbreaking Research Findings
5/24/2012 10:34:58 AM
SAN CLEMENTE, Calif.--(BUSINESS WIRE)--Metagenics, Inc., a nutrigenomics and lifestyle medicine company focused on improving health and reversing chronic illness, today announced that three separate studies show that a novel phytonutrient reduces inflammation, the root cause of many chronic illnesses, such as heart disease, obesity and intestinal hyperpermeability, or “leaky gut.” These groundbreaking studies have been accepted for publication in the journals Nutrition, PLoS ONE and Atherosclerosis.
comments powered by